Researchers at the University of Michigan Health Rogel Cancer Center are one step closer to understanding how pediatric DIPG tumors work. Rogel researchers, led by Daniel Wahl, M.D., Ph.D., wanted to understand how a specific mutation affects DIPG tumor metabolism and influences radiation resistance. Read more to vind out the results of the study and additional findings.
